Ex-OpenAI science head Kevin Weil launches startup with $215 million

Kevin Weil, the former OpenAI executive who led the company's AI-for-science efforts, has launched a new startup that uses artificial intelligence to speed up a key step in drug development. The company has raised $215 million.

• Kevin Weil previously led AI-for-science work at OpenAI
• The startup applies AI to accelerate a drug development stage
• It has raised $215 million in funding